Form D · Biotechnology

AMBRX INC

La Jolla, CA · CIK 0001264647

Offering snapshot reported Apr 1, 2009 · SEC filing

Reported sold
$10M
Offering amount: $10M
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 1, 2009Initial$10,000,000No comparisonNot reportedSEC filing
Jul 27, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Jan 25, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Apr 15, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-58840

Source: Form D, filed Apr 1, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Douglas W. Axelrod Executive
Crispina Calsada Executive
Ho Sung Cho Executive
John D. Diekman Director
Richard D. Di Marchi Director
Shehan Dissanayake Director
Kevin L. Eastwood Executive
Stephen W. Kaldor Director, Executive
Allan Marchington Director
Peter G. Schultz Director
David B. Singer Director
John W. Wallen, Iii Executive
August M. Watanabe Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
10975 North Torrey Pines Road
La Jolla, CA, 92037